Trailing-twelve-month (TTM) revenue is $651.12 Million with a year-over-year growth of +33.25%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $133,349,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-03 |
| Q4 FY2025Period ended 2026-01-03 | $145,792,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-13 |
| Q1 FY2026Period ended 2026-04-04 | $170,897,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-04 |
| Q2 FY2026Period ended 2026-07-04 | $201,079,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $651,117,000 |
Current P/S: $18,359,072,000 market capitalization ÷ $651,117,000 TTM revenue = 28.20x.
Market capitalization source: FMP quote. Quote observed 2026-10-02T20:00:01.000Z. Latest revenue period ended 2026-07-04.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-07-04): $201.08M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-02T20:55:45.903Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2022-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-01-03 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20182018-12-29 · USD | FY20192019-12-28 · USD | FY20202021-01-02 · USD | FY20212022-01-01 · USD | FY20222022-12-31 · USD |
|---|---|---|---|---|---|
| License and Service | N/A | $22M | $20M | $20M | $17M |
| Product Revenue, Direct | $50M | $51M | N/A | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202021-01-02 · USD | FY20212022-01-01 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252026-01-03 · USD |
|---|---|---|---|---|---|---|
| Americas | $62M | $81M | $100M | $146M | $101M | $103M |
| Asia | $305M | $385M | $465M | $444M |
$651.12M
$651.12 Million
+33.25%
vs. $488.64M a year ago (TTM)
+7.58%
5 Year compound annual growth rate
1 Year
+33.25%
3 Year
(3.41%)
5 Year
+7.58%
10 Year
+4.82%
15 Year
+4.92%
20 Year
+5.39%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $523.26M | +$13.86M | +2.72% |
| 2024 | $509.40M | ($227.75M) | (30.90%) |
| 2023 | $737.15M | +$76.80M | +11.63% |
| 2022 | $660.36M | +$145.03M | +28.14% |
| 2021 | $515.33M | +$107.21M | +26.27% |
| 2020 |
TTM Growth
+33.25%
3-Year CAGR
(3.41%)
5-Year CAGR
+7.58%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-02T20:55:45.903Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-01.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| Product Revenue, Distributors |
|---|
| $331M |
| $332M |
| N/A |
| N/A |
| N/A |
| $354M |
| CHINA | N/A | N/A | N/A | N/A | N/A | $273M |
|---|
| Europe | $41M | $50M | $95M | $148M | $75M | $67M |
|---|
| JAPAN | N/A | N/A | N/A | N/A | N/A | $29M |
|---|
| Other Asia | N/A | N/A | N/A | N/A | N/A | $52M |
|---|
| $408.12M |
| +$4.03M |
| +1.00% |
| 2019 | $404.09M | +$5.29M | +1.33% |
| 2018 | $398.80M | +$12.84M | +3.33% |
| 2017 | $385.96M | ($41.09M) | (9.62%) |
| 2016 | $427.05M | +$21.09M | +5.19% |
